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Abstract
Background: NK cells express several specialized receptors through which they recognize and discriminate virally-infected/
tumor cells efficiently from healthy cells and kill them. This ability to lyse is regulated by an array of inhibitory or activating
receptors. The present study investigated the frequency of various NK receptors expressed by NK cell subsets from HIV-
infected TB patients. The effect of IL-15+IL-12 stimulation on the expression of NK receptors was also studied.
Methodology/Principal Findings: The study included 15 individuals each from normal healthy subjects, pulmonary
tuberculosis patients, HIV-infected individuals and patients with HIV and tuberculosis co-infection. The expression of NK cell
receptors was analyzed on two NK cell subsets within the peripheral blood: CD16+CD32 and CD56+CD32 using flow
cytometry. The expression of inhibitory receptors (CD158a, CD158b, KIRp70, CD85j and NKG2A) on NK subsets was
increased in HIV, when compared to NHS. But the response in HIV-TB was not uniform. Stimulation with IL-15+IL-12
dropped (p,0.05) the expression of CD85j and NKG2A in HIV. The basal expression of natural cytotoxicity receptors (NKp30
and NKp46) on NK cell subsets was lowered (p,0.05) in HIV and HIV-TB as compared to NHS. However, the expression of
NKp44 and NKG2D was elevated in HIV. Enhanced NKp46 and NKG2D expression was observed in HIV with IL-15+IL-12
stimulation. The coreceptor NKp80 was found to be expressed in higher numbers on NK subsets from HIV compared to
NHS, which elevated with IL-15+IL-12 stimulation. The expression of NK receptors and response to stimulation was primarily
on CD56+CD32 subset.
Conclusions/Significance: IL-15+IL-12 has an immunomodulatory effect on NK cell subsets from HIV-infected individuals viz
down-regulation of iNKRs, elevation of activatory receptors NKp46 and NKG2D, and induction of coreceptor NKp80. IL-
15+IL-12 is not likely to be of value when co-infected with TB probably due to the influence of tuberculosis.
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Introduction
Natural Killer (NK) cells represent a highly specialized
lymphoid population that lack antigen specific receptors, but
can lyse tumor and virus-infected cells, without prior sensitization
[1]. They commonly express a variety of nonexclusive pheno-
typic markers such as CD16, CD56, CD57, and to some extent
CD8 [2]. Unlike T and B lymphocytes, NK cells do not
rearrange genes encoding receptors for antigen recognition, but
they have developed the ability to recognize self-MHC class I or
class I–like molecules through a unique class of receptors, NK
cell receptors (NKRs), that can inhibit or activate NK cell killing
[3].
The effector functions of NK cells are finely regulated by a series
of inhibitory or activating receptors [4]. The inhibitory receptors,
specific for major histocompatibility complex (MHC) class I
molecules, allow NK cells to discriminate between normal cells
and cells that have lost the expression of MHC class I.
Accordingly, lack of interaction of these receptors with MHC
class I molecules may result in the killing of the target cells [5].
This occurs when target cells have lost or express insufficient
amounts of MHC class I molecules. The inhibitory form of NK
receptors provides the protective immunity through recognizing
class I MHC molecules with self-peptides on healthy host cells.
The activating or the noninhibitory NK receptors mediate the
killing of tumor or virally infected cells through their specific
ligand recognition [6].
The inhibitory NK receptors (iNKRs) which are responsible for
delivering inhibitory signal include the human killer cell Ig-like
receptors (KIRs), leukocyte Ig-like receptors (LIRs) and members
of NKG2 family. All the iNKRs have characteristic immuno
tyrosine inhibitory motifs (ITIM) in their intracellular domain
through which the intracellular signal transduction takes place. In
contrast, activating receptors carry immuno tyrosine activation
motifs (ITAM) in their cytoplasmic domain. Activating receptors
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e37448include 2B4, the natural cytotoxicity receptors- NKp46, NKp30,
and NKp44, the noninhibitory isoforms of KIRs and LIRs,
CD94/NKG2C and CD94/NKG2E heterodimers, and NKG2D
homodimer.
Despite extensive progress in the recent years, many of the
intriguing and specific NK receptors are still poorly understood
with respect to ligand specificity and signaling properties. NK cells
from HIV-infected individuals had been shown to exhibit reduced
natural cytotoxicity [7] and more so in patients co-infected with
TB [8]. The present study hypothesizes that the NK receptors,
which are known to involve in cytotoxicity might be affected
during HIV infection. In this context, the expression profile of
various NK receptors in infected and un-infected individuals was
studied separately on CD56+ and CD16+ cells.
The stimulatory effect of cytokines on NK activity has been well
documented [9]. IL-2–activated NK cells are known to increase
the lytic activity compared with circulating NK cells and are able
to lyse otherwise NK cell–resistant targets [10]. The potential
effects of IL-15+ IL-12 on the enhancement of NK activity in HIV
positive individuals have been demonstrated by us [8,11,12].
Hence, the present study assessed the effect of IL-15+ IL-12 on the
expression of NK surface receptors in HIV positive individuals
with and without TB co-infection.
Materials and Methods
Study Participants and Ethics
This study was approved by the Institutional ethics committee.
All the study participants were informed about the study protocol
and gave written consent to participate in this study. Patients were
recruited from the Government Hospital of Thoracic Medicine,
Tambaram Sanatorium, Chennai between September 2007 and
March 2009. Healthy volunteers from the laboratory were
recruited as normal healthy subjects.
The study participants consist of four groups which included
normal healthy subjects [NHS, N=15, age=22–29 (medi-
an=23)], pulmonary tuberculosis patients [TB, N=15,
age=22–55 (median=39)], HIV-infected individuals [HIV,
N=15, age=23–44 (median=30)] and HIV co-infected tuber-
culosis patients (HIV-TB, N=15, age=26–46 (median=34)].
The TB patients were diagnosed based on clinical manifestation
typical for M. tuberculosis, radiologic analysis and sputum smear
positivity. HIV seropositivity was determined by 2 rapid EIAs:
HIV TRI-DOT (J. Mitra & Co, India) and Retroquic (Qual-
trodiagnostics, India). CD4 count ranged from 13 to 643 cells/
mm
3 (median 205) for HIV and 12 to 388 cells/mm
3 (median 141)
for HIV-TB. All the subjects recruited in the study were naı ¨ve for
anti-tuberculous and anti-retroviral therapy.
Separation of PBMCs
The PBMCs were separated from blood samples by density
gradient centrifugation using Histopaque (Sigma-Aldrich Corp, St.
Louis, MO, USA). The cells were washed twice with Hanks
balanced salt solution (Sigma-Aldrich Corporation, St. Louis, MO,
USA) and resuspended at a density of 2610
6 cells/ml in RPMI-
1640 (Sigma-Aldrich Corporation, St. Louis, MO, USA) supple-
mented with heat inactivated 10% human AB serum (Sigma-
Aldrich Corporation, St. Louis, MO, USA) and 16 antibiotic/
antimycotic solution (Invitrogen Corporation, CA, USA).
In vitro Culture of PBMCs with Recombinant Cytokines
PBMCs at a density of 2610
6 cells/ml were cultured overnight
in 24 well tissue culture plates (Costar, Corning Inc., NY, USA) in
the presence and absence of purified rhIL-15 (BD Biosciences, San
Jose, CA, USA) and purified rhIL-12 (R&D Systems Inc., MN,
USA) at a concentration of 10 ng each per ml of culture at 37uC,
in 5% CO2 atmosphere. The optimum concentration required for
stimulation was determined in preliminary experiments (data not
shown).
Measurement of NK Surface Receptors
The cultured cells were washed twice using 16 PBS and
incubated with purified mouse anti-human antibodies specific for
CD158a, CD158b, CD85j, CD94, NKp80 and NKG2D (BD
Biosciences, San Jose, CA, USA); KIRp70 and NKG2A (Im-
munotech, Fullerton, CA, USA) for 30 min at 4uC followed by
incubation with Phycoerythrin labeled goat anti-mouse IgG
antibody (Jackson ImmunoResearch Laboratory, West Grove,
PA, USA) for 20 min. PBS containing 1% BSA was used
throughout the experiment for blocking Fc receptors. After
incubation, cells were stained for other surface receptors CD3-
FITC (UCHT1), CD16-PECy5 (3G8), CD56-PECy5 (B159) and
CD8-APC (RPA-T8) (BD Biosciences, San Jose, CA, USA),
washed and finally resuspended in 0.5% paraformaldehyde. For
those tubes with all direct labels CD244 (BD Biosciences, San Jose,
CA, USA); NKp30, NKp44 and NKp46 (Beckman Coulter Inc.,
Fullerton, CA, USA), staining was carried out in a single step. The
tubes containing cells were vortexed and acquired in BD
FACSCalibur flow cytometer (BD Biosciences, San Jose, CA,
USA). The data collected from FACSCalibur was analyzed using
FlowJo software (Tree Star Inc., San Carlos, CA, version 7.1.1,
USA). At least 35,000 events within lymphocyte gate were
collected per sample.
Statistical Analysis
The data were analyzed using the GraphPad Prism version 4.03
for Windows (GraphPad software, San Diego, CA, USA). Data are
presented as mean 6 standard error mean (SEM) of 15 subjects in
each group. Statistical comparisons between NHS and other
groups were performed using one-way ANOVA followed by
Tukey’s multiple comparison test and the significant values are
denoted by *. Statistical analysis between basal and IL-15+ IL-12
stimulation was carried out using Mann-Whitney U test and the
significance is showed as #.Ap value of ,0.05 was considered
statistically significant.
Results
Expression of Inhibitory NK Receptors (iNKRs)
The proportion of various iNKRs- CD158a, CD158b, KIRp70,
CD85j and NKG2A expressed by NK cell subsets were measured
and are as follows:
CD158a, CD158b and KIRp70. Representative flow cyto-
metric dot plot of CD16+ cells and CD56+ cells (Fig. 1a) and the
histograms showing the expression of CD158a from NK cell
subsets (CD16+CD32 and CD56+CD32) among four different
groups (Fig. 1b) are presented. The basal level expression of
CD158a was reduced (p,0.05) in TB for the NK cells subsets,
when compared with NHS. In HIV, the basal CD158a expression
was elevated for CD16+CD32 and CD56+CD32 subsets as
compared to NHS. As compared to NHS, in HIV-TB patients
basal CD158a expression showed a varied response, elevated for
CD56+CD32 subset while no significant change for
CD16+CD32 cells. After stimulation with IL-15+ IL-12, a gener-
alized reduction of CD158a was observed however significant
reduction was found in CD56+CD32 cells from HIV (Fig. 1c).
The expression pattern of CD158b and KIRp70 on NK cell
subsets was similar to CD158a (data not shown).
NK Receptors in HIV or/and TB
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CD85j on both NK cell subsets compared to NHS. The expression
of CD85j in HIV and HIV-TB was found to be elevated (p,0.05)
on CD56+CD32 cells, while no such changes was observed with
CD16+CD32 cells, when compared with NHS. When the cells
were treated with IL-15+ IL-12, there was a decline in the
expression of CD85j on CD56+CD32 subset in HIV-infected
individuals (Fig. 2).
NKG2A. The basal expression of NKG2A by NK cell subsets
was observed to be reduced in TB compared to NHS. However,
NKG2A expression was up-regulated in HIV-infected individuals,
which was significant for NK subsets. When the cells were treated
with IL-15+ IL-12, there was a significant decline in the expression
of this receptor on CD16+CD32 and CD56+CD32 cells in HIV-
infected individuals (Fig. 3).
Expression of Activating and Natural Cytotoxicity
Receptors (NCRs)
NKp46 and NKp30. In comparison to NHS, the basal
frequency of NKp46 on NK subsets was down-regulated (p,0.05)
in TB, HIV and dually infected individuals. Upon treatment with
IL-15+ IL-12, the NK subsets from HIV have shown up-
regulation of NKp46 (Fig. 4). The expression profile of NKp30
on NK cell subsets after IL-15+ IL-12 stimulation did not differ
among groups (data not shown).
NKp44. The expression of the other NCR, NKp44 by NK
cell subsets was found to be lower in TB and HIV-TB, while
elevated significantly in HIV-infected individuals, compared to
NHS. Stimulation with IL-15+ IL-12 induced elevation of NKp44
expression in NHS, but did not bring about any significant
changes in TB, HIV and HIV-TB patients (data not shown).
NKG2D. The number of CD16+CD32 cells expressing
NKG2D was found to be lower in TB than NHS. In HIV and
HIV-TB, the basal NKG2D expression was higher (p,0.05) only
for CD56+CD32 cells. Upon stimulation with IL-15+ IL-12, the
NKG2D expression among HIV-infected individuals was in-
creased for CD56+CD32 subset but did not affect the
CD16+CD32 cells (Fig. 5).
Expression of Coreceptors on NK Cells
CD94. The iNKRs coreceptor, CD94 like their dimer
NKG2A was found to express proportionately lower by the NK
cell subsets in TB and HIV-TB patients. However, CD94
coreceptor was expressed more in HIV-infected individuals.
Treatment with IL-15+ IL-12 did not had any effect on NK
subsets from the different groups (data not shown).
NKp80. The basal expression of NCRs coreceptor, NKp80
on NK cell subsets was reduced in TB, HIV and HIV-TB,
compared to NHS. On stimulation, the NKp80 expression from
HIV-infected individuals was upregulated by CD56+CD32 cells
alone (Fig. 6).
CD244. The frequency of CD244 expression by NK subsets
did not vary between the various groups. Stimulation with IL-15+
IL-12 also had no effect on the CD244 expression in any of the
group studied (data not shown).
Discussion
NK cells distinguish between normal healthy cells and abnormal
cells by using a sophisticated repertoire of cell surface receptors
Figure 1. Expression of inhibitory NK receptor CD158a. Dot plots of CD16+ and CD56+ cells (a), representative histograms of CD16+CD32
and CD56+CD32 cells from the four groups showing the expression of CD158a (b). Dashed line in histogram refers to unstimulated while the thick
line represents IL-15+IL-12 stimulation. Effect of IL-15+IL-12 on the CD158a expression from four different groups obtained from 15 individuals (c).
Data are presented as median 6 IQR. Statistical comparisons between NHS and other groups were performed and the significant values are denoted
by *. Statistical analysis between basal and IL-15+ IL-12 stimulation were also carried out and the significant values are showed as #.Ap value of
,0.05 was considered statistically significant.
doi:10.1371/journal.pone.0037448.g001
Figure 2. Expression of inhibitory NK receptor CD85j. The CD85j expression on CD16+CD32 and CD56+CD32 cells from different groups in
the presence/absence of IL-15+IL-12 stimulation is depicted here. Data are given as median 6 IQR from 15 individuals each. Statistical comparisons
between NHS and other groups were performed and the significant values (p,0.05) are shown as *. Statistical significance (p,0.05) between basal
and IL-15+ IL-12 stimulation were represented by #.
doi:10.1371/journal.pone.0037448.g002
NK Receptors in HIV or/and TB
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Recent NK cell research has not only revealed insight into the
mechanisms of NK cytotoxicity and the regulation via activating
and inhibitory receptors, but also pointed out the heterogeneity of
NK cells. This cell lineage can be subdivided into several
subpopulations according to their functional properties and/or
particular phenotypes.
HIV infection is characterized by profound and inappropriate
immune activation and progressive immunodeficiency [13], which
includes impaired function of NK cells [7] and CD8 cells [14].
The effect of HIV infection on NK cell phenotype and function
particularly when co-infected with TB remains to be fully
elucidated. In the present study, NK cell subsets from TB, HIV
and dually infected individuals were analyzed for the expression of
NK cell surface receptors. The CD56 and CD16 cells are
examined separately for the different NK receptors and hence the
traditional NK subsets are not described. In addition, the effect of
in vitro IL-15+ IL-12 on the expression of various receptors was
investigated from the NK cell subsets of different groups.
The KIR family consists of transmembrane glycoproteins of the
Ig superfamily expressed on 1–8% of NK cells, which are involved
in recognition of MHC class I molecules on target cells and inhibit
cytotoxicity. The CD158a (p58.1) and CD158b (p58.2) molecules
regulate NK cell mediated cytolytic activity by interacting with
Figure 3. Expression of inhibitory NK receptor NKG2A. NKG2A expression at basal and IL-15+IL-12 stimulation on CD16+CD32 and
CD56+CD32 cells from different groups is shown. Data are given as median 6 IQR from 15 individuals in each group. Statistical comparisons
between NHS and other groups were performed and the significant values (p,0.05) are denoted by *. Statistical analysis between basal and IL-15+ IL-
12 stimulation were also carried out and the significant values a(p,0.05) re showed as #.
doi:10.1371/journal.pone.0037448.g003
Figure 4. Expression of NKp46. Effect of IL-15+IL-12 on the NKp46 expression from four different groups obtained from 15 individuals. Data for
CD16+CD32 and CD56+CD32 subpopulation are presented as median 6 IQR. Statistical comparisons between NHS and other groups were
performed and the significant values (p,0.05) are shown as *. Statistical significance (p,0.05) between basal and IL-15+ IL-12 stimulation were
represented by #.
doi:10.1371/journal.pone.0037448.g004
NK Receptors in HIV or/and TB
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for HLA–B molecules [16]. Unlike KIRs that recognize the a1
and a2 domains of human leukocyte antigens with the bound self
peptide, the LIRs such as CD85j recognize the nonpolymorphic
a3 domain of classical and non-classical HLA molecules. Members
of NKG2 family dimerize with CD94 to form a heterodimer that
recognize the nonclassical HLA–E molecules [17]. HIV differen-
tially down-regulates MHC class I molecules (HLA–A and B) on
target cells to evade killing, but maintains normal expression of
HLA–C and E, which are predominant ligands for inhibitory
receptors on NK cells [18].
The basal expression of KIR receptors (CD158a, CD158b and
KIRp70) on NK subsets was found to be reduced in TB, increased
in HIV, while altered in HIV-TB, when compared to NHS.
However, the basal expression of other iNKRs (CD85j and
NKG2A) from HIV was enhanced (p,0.05) in NK subsets. The
elevated inhibitory NK receptors in HIV-infected individuals
coincides with the previous reports [19,20,21]. Up-regulation of
iNKRs seems to be a direct effect of HIV infection, since up-
regulation of iNKRs was not observed in pulmonary TB patients.
In contrast, decreased KIR molecules on CD56+ cells from HIV-
infected individuals have also been reported [22,23].
Figure 5. Expression of activatory NK receptor NKG2D. NKG2D expression on CD16+CD32 and CD56+CD32 cells from different groups in the
presence/absence of IL-15+IL-12 stimulation is depicted here. Data are given as median 6 IQR from 15 individuals each. Statistical comparisons
between NHS and other groups were performed and the significant values (p,0.05) are denoted by *. Statistical analysis between basal and IL-15+ IL-
12 stimulation were also carried out and the significant values a(p,0.05) re showed as #.
doi:10.1371/journal.pone.0037448.g005
Figure 6. Expression of coreceptor NKp80 on NK cells. The expression of coreceptor NKpp80 at basal and after IL-15+IL-12 stimulation from
different groups is shown. Data are given as median 6 IQR from 15 individuals in each group. Statistical comparisons between NHS and other groups
were performed and the significant values (p,0.05) are shown as *. Statistical significance (p,0.05) between basal and IL-15+ IL-12 stimulation were
represented by #.
doi:10.1371/journal.pone.0037448.g006
NK Receptors in HIV or/and TB
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of iNKRs-CD158a, NKG2A and CD85j in HIV-infected individ-
uals which was predominantly observed for CD56+CD32 cells.
Reduction in iNKRs during HIV infection might be beneficial to
the host as lesser number of ligands is sufficient to activate NK
cells. IL-15 has been shown to play a widespread role in the
induction of the CD94/NKG2A receptor [24]. Also, transforming
growth factor-b (TGF-b), a cytokine with prevalent inhibitory
function, has also been shown to induce in vitro expression of
CD94/NKG2A on CD56+ T-cells [25]. The understanding of
cytokine-mediated inhibitory NKR regulation had been so far
confined to CD94/NKG2A. HIV-infected individuals in whom
viral replication was suppressed by highly active anti-retroviral
therapy (HAART), have normal expression of iNKRs on NK cells
[20]. Moreover, the NK receptor expression and activity have
been shown to normalize in parallel with ART-induced reduction
of circulating IL-10 levels [21].
The major NK cell activating receptors are NKG2D and the
natural cytotoxicity receptors: NKp30 (NCR1), NKp46 (NCR3)
and NKp44 (NCR2) [4]. Fresh NK cells constitutively express
NKp30 and NKp46, while the NKp44 receptors are expressed
progressively after NK cell activation [26]. To date, the NKp44
gene has only been identified in humans [27], while genes for
other NCR members have also been described in rodents [28,29].
The cellular ligands of these NCRs have not yet been identified,
but studies suggest that they are not expressed on normal tissues,
but can be induced under stress and certain pathological
conditions, including viral infections [4]. The NKG2D is not
related to other highly related NKG2 family members. NKG2D
does not form dimers with CD94 and are constitutively expressed
on NK cells.
The basal expression of constitutively expressed NCRs (NKp30
and NKp46) on NK cell subsets was lowered (p,0.05) in TB, HIV
and dually infected individuals as compared to NHS. The
expression of NKp44 and NKG2D was found elevated (p,0.05)
in HIV-infected individuals (mainly CD56+CD32 cells) com-
pared to NHS. The expression of NCRs is markedly decreased
among HIV viremic individuals, along with a concomitant
decrease in NK cytolytic activity [19,20,21,30,31]. Though there
exist consensus in literature that NKp46 and NKG2D expression
on NK cells is reduced in HIV viremia, the basal expression in
NHS was reported to vary widely [19,30,32,33,34]. Possible
explanation for this variation include use of peripheral blood
lymphocytes vs purified NK cells, analysis within total NK cells vs
subsets, geographical variation between cohorts and so on. The
percentage of CD56dim cells that express NKp46 and NKp30 and
their cytolytic activity decrease with disease progression [30]. On
the other hand, concomitant increase of KIR density is also
observed on NK cells, thus, setting the basis for an increased
inhibitory potential of cytolytic cells [19]. The downregulation of
activating receptors and upregulation of KIRs potentiate func-
tional defects in NK-cell-mediated cytotoxicity regardless of the
NK cell subpopulation.
The decreased expression of activating and inhibitory NK
receptors in TB and HIV-TB might be due to immune
deregulation of NK cell function owing to the severe manifesta-
tions of TB disease. A direct link between NK cells and M.
tuberculosis-infected cells have been found to be mediated by the
interaction of NKp46- and NKG2D-activating receptors on NK
cells with infected monocytes [35]. Patients with recent onset of
pulmonary TB have been shown to have low-level expression of
both NKp46 and NKp30 [36]. NKp44 has been reported to
interact directly to cell-free mycobacteria or other bacteria [37]
and to play a role in the recognition of virus-infected cells. Direct
interaction of NKp44 with virus-infected cells has also been shown
with regard to the envelope protein of flavivirus (WestNile virus,
dengue Virus, HCV) [38]. In chronic HCV infection, conflicting
evidence with respect to NCRs and NKG2D expression on NK
cells have been reported [39,40].
Stimulation with IL-15+ IL-12 elevated NKp46 (HIV), NKp44
(NHS) and NKG2D (HIV) expression in the CD56+CD32 cells,
but did not affect any significant changes in TB and HIV-TB
patients. The elevated expression of activating NK receptor might
be beneficial to host during HIV infection, as it contributes to
more NK cell activation and thereby killing of virus-infected cells.
The NK cell expression of NKG2D was increased by culturing
with IL-15 or TNF-a, but is significantly down-regulated in the
presence of TGF-b [41].
CD94 can be expressed on the cell surface as a disulfide-linked
homo/hetero dimer with NKG2A or NKG2C. NKG2A has an
ITIM in its cytoplasmic domain and CD94/NKG2A hetero-
dimers function as inhibitory receptor [42]. Conversely, CD94/
NKG2C heterodimers serve as activating receptors and require
association with the DAP12 adapter protein that has ITAM in the
cytosplasmic tail, for stable expression on the cell surface and for
signaling. Unlike the KIR receptors that are stably maintained
once expressed, CD94/NKG2 receptors on NK cells and T cells
are modulated by cytokines in the environment. IL-15, TGF-b and
IL-12 have been shown to induce CD94/NKG2 on human T cells
in vitro [43].
The present study shows enhanced expression of CD94 on NK
subsets in HIV-infected individuals as reported earlier [20]. CD94
per se does not bind any MHC ligand, but is essential for the
surface expression of NKG2 family of NK receptors [44,45]. As it
may associate with activating (NKG2C) and inhibitory (NKG2A)
molecules, it is not clear from the present study whether enhanced
expression of CD94 on these cells in HIV-infected individuals is
associated with enhanced expression of activating or of inhibitory
NKG2 receptors on these cells. Clearly, further work is needed to
address this issue.
NKp80 is a type II transmembrane protein with a C-type lectin
domain in its extracellular region. The CD244 (2B4) molecule
belongs to the Immunoglobulin superfamily of proteins and is
structurally related to CD2-like molecules. In humans, CD244 is
expressed on NK cells, CD8+ T cells, monocytes and basophils,
suggesting a broader role in leukocyte activation [46]. The
coreceptors NKp80 and CD244 synergize with NCRs and
NKG2D in the NK mediated cytolysis [47].
The NCR coreceptor, NKp80 was found to be expressed in low
numbers on CD56+CD32 NK subsets from HIV and HIV-TB
compared to NHS. Decreased CD244 expression in HIV-infected,
compared to HIV-uninfected individuals was previously observed
[20], however, we did not find any significant difference between
groups. Stimulation with IL-15+ IL-12 elevated NKp80 expression
on CD56+CD32 subset from HIV while stimulation had no effect
on CD244 expression. The CD244 expression of NK cells from
HIV-infected individuals is believed to vary over time- reduced at
12 months after initiation of HAART, but increased to a level
comparable to that of healthy individuals after 36 months [48].
It is interesting in the context of CD56+CD32 NK cells, that it
is clear from the data presented that TB patients have different
responses to HIV patients and that HIV-TB co-infected patients
have similar responses to HIV patients rather than TB patients.
To summarize, IL-15+ IL-12 has an immunomodulatory effect
on NK cell subsets from HIV-infected individuals viz down-
regulation of iNKRs, elevation of activatory receptors NKp46 and
NKG2D, and induction of coreceptor NKp80. The effect of IL-
15+ IL-12 on NK cell populations of HIV-TB patients is minimal
NK Receptors in HIV or/and TB
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revealed that natural killer receptors are differentially expressed
and regulated on NK cell subpopulations and are differently
affected by HIV. As far as we know, this is the first study to
demonstrate the various surface receptors on NK subsets in HIV-
infected individuals associated with TB. Further studies on
particular NK populations are necessary to identify the main
effectors in the interplay of innate and acquired immune functions.
Analysis of this interaction is important for the understanding of
the NK cell regulation and development of new immune-based
interventions in HIV disease.
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